rs897870181
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001303256.3(MORC2):c.1446G>T(p.Glu482Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. E482E) has been classified as Likely benign.
Frequency
Consequence
NM_001303256.3 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease axonal type 2ZInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
- developmental delay, impaired growth, dysmorphic facies, and axonal neuropathyInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001303256.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MORC2 | NM_001303256.3 | MANE Select | c.1446G>T | p.Glu482Asp | missense | Exon 15 of 26 | NP_001290185.1 | ||
| MORC2 | NM_001303257.2 | c.1446G>T | p.Glu482Asp | missense | Exon 15 of 26 | NP_001290186.1 | |||
| MORC2 | NM_014941.3 | c.1260G>T | p.Glu420Asp | missense | Exon 16 of 27 | NP_055756.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MORC2 | ENST00000397641.8 | TSL:5 MANE Select | c.1446G>T | p.Glu482Asp | missense | Exon 15 of 26 | ENSP00000380763.2 | ||
| MORC2 | ENST00000215862.8 | TSL:1 | c.1260G>T | p.Glu420Asp | missense | Exon 16 of 27 | ENSP00000215862.4 | ||
| MORC2 | ENST00000674576.1 | n.2892G>T | non_coding_transcript_exon | Exon 3 of 14 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461574Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727086 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2Z Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 482 of the MORC2 protein (p.Glu482Asp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MORC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 581365). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MORC2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not provided Uncertain:1
BP4
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at